2025 HCPCS Code J0752
Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
TAGS: treatment prophylaxis approved| Short Description | Hiv prep, oral lenacapavir |
| HCPCS Action Code | A - Add procedure or modifier code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | October 01, 2025 |
| HCPCS Action Effective Date | October 01, 2025 |
| HCPCS Pricing Indicator Code | 57 - Other carrier priced |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J9228 - Ipilimumab injection
- J9229 - Inj inotuzumab ozogam 0.1 mg
- J9230 - Mechlorethamine hcl inj
- J9245 - Inj melpha hydroch nos 50 mg
- J9246 - Inj., evomela, 1 mg
- J9247 - Inj, melphalan flufenami 1mg
- J9248 - Inj melphalan (hepzato) 1 mg
- J9249 - Inj, melphalan (apotex) 1 mg
- J9250 - Methotrexate sodium inj
- J9255 - Inj, methotrexate (accord)
- J9258 - Paclitaxel (teva)
- J9259 - Paclitaxel (american regent)
- J9260 - Inj methotrexate sodium 50mg
- J9261 - Nelarabine injection
- J9262 - Inj, omacetaxine mep, 0.01mg
- J9263 - Oxaliplatin
- J9264 - Paclitaxel protein bound
- J9265 - Paclitaxel injection
- J9266 - Pegaspargase injection
- J9267 - Paclitaxel injection